Literature DB >> 7697531

Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo.

M W Hornef1, H J Wagner, A Kruse, H Kirchner.   

Abstract

Epstein-Barr virus (EBV) has a marked tropism for cells of the immune system, and infection can result in profound immunomodulatory effects. In order to examine the role of cytokines during the acute phase of infectious mononucleosis, we studied the levels of different interleukins (ILs), interferons (IFNs), and the soluble IL-2 receptor (sIL-2R) in serum samples of 20 patients. We found elevated levels of IL-2, IL-6, sIL-2R, and IFN-gamma. Whereas the peak of IL-2 and IL-6 concentration occurred during the first week (P < 0.01), the largest amounts of sIL-2R were measured during the second week (P < 0.01). IFN-gamma levels were only enhanced during the first week. In addition, we investigated the ability to produce cytokines in response to mitogenic stimulation in a whole-blood assay of 11 patients compared with healthy blood donors. In the whole-blood assay of patients compared with controls after stimulation with lipopolysaccharide, we measured more than 10-fold elevated levels of tumor necrosis factor alpha (P < 0.01), 3-fold elevated levels of IL-1 beta (P < 0.01), and about 2-fold increased amounts of IL-6 (P < 0.01). A significant enhancement in sIL-2R and IFN-gamma concentration was found in the assay after stimulation with phytohemagglutinin after 24 h of incubation (P < 0.01). Collectively, our data seem to indicate that monocytes are strongly activated during infectious mononucleosis. Monocytes and monocyte-derived factors may play an important role in the pathogenesis of infectious mononucleosis and, together with T lymphocytes, may be partly responsible for clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697531      PMCID: PMC170129          DOI: 10.1128/cdli.2.2.209-213.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  25 in total

1.  Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction.

Authors:  H J Wagner; G Bein; A Bitsch; H Kirchner
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  Tumor necrosis factor selectively inhibits activation of human B cells by Epstein-Barr virus.

Authors:  O Janssen; D Kabelitz
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

3.  T lymphocytes in infectious mononucleosis. I. T cell death in vitro.

Authors:  D J Moss; C J Bishop; S R Burrows; J M Ryan
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

4.  Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies.

Authors:  M De Waele; C Thielemans; B K Van Camp
Journal:  N Engl J Med       Date:  1981-02-19       Impact factor: 91.245

5.  Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.

Authors:  M Lotz; C D Tsoukas; S Fong; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

6.  Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.

Authors:  M Lotz; C D Tsoukas; S Fong; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

7.  Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma.

Authors:  M Lotz; C D Tsoukas; S Fong; D A Carson; J H Vaughan
Journal:  Eur J Immunol       Date:  1985-05       Impact factor: 5.532

8.  The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies.

Authors:  E L Reinherz; C O'Brien; P Rosenthal; S F Schlossman
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

9.  Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.

Authors:  G Tosato; T L Gerrard; N G Goldman; S E Pike
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

10.  Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome.

Authors:  A Linde; B Andersson; S B Svenson; H Ahrne; M Carlsson; P Forsberg; H Hugo; A Karstorp; R Lenkei; A Lindwall
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

View more
  9 in total

Review 1.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function.

Authors:  Jordan S Orange; Sumita Roy-Ghanta; Emily M Mace; Saumya Maru; Gregory D Rak; Keri B Sanborn; Anders Fasth; Rushani Saltzman; Allison Paisley; Linda Monaco-Shawver; Pinaki P Banerjee; Rahul Pandey
Journal:  J Clin Invest       Date:  2011-03-07       Impact factor: 14.808

Review 3.  Innate immune responses against Epstein Barr virus infection.

Authors:  Obinna Chijioke; Tarik Azzi; David Nadal; Christian Münz
Journal:  J Leukoc Biol       Date:  2013-06-28       Impact factor: 4.962

4.  Interleukin-4 and interferon- γ levels in Epstein-Barr virus-associated infectious mononucleosis and nasopharyngeal carcinoma.

Authors:  Dyah R Budiani; Sofia M Haryana; Wihaskoro Sosroseno
Journal:  J Res Med Sci       Date:  2011-01       Impact factor: 1.852

5.  Primary Epstein-Barr virus infection does not erode preexisting CD8⁺ T cell memory in humans.

Authors:  Oludare A Odumade; Jennifer A Knight; David O Schmeling; David Masopust; Henry H Balfour; Kristin A Hogquist
Journal:  J Exp Med       Date:  2012-03-05       Impact factor: 14.307

6.  SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma.

Authors:  Yanzhang Luo; Tin Seak Mok; Xiuxian Lin; Wanling Zhang; Yizhi Cui; Jiahui Guo; Xing Chen; Tao Zhang; Tong Wang
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

7.  Common Respiratory Tract Infections as Psychological Entities: A Review of the Mood and Performance Effects of Being Ill.

Authors:  Tania Mahoney; Peter Ball
Journal:  Aust Psychol       Date:  2011-02-02

Review 8.  Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges.

Authors:  Lynda Coughlan; Teresa Lambe
Journal:  Vaccines (Basel)       Date:  2015-04-14

9.  Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays.

Authors:  Xiaofang Bian; Garrick Wallstrom; Amy Davis; Jie Wang; Jin Park; Andrea Throop; Jason Steel; Xiaobo Yu; Clive Wasserfall; Desmond Schatz; Mark Atkinson; Ji Qiu; Joshua LaBaer
Journal:  Diabetes       Date:  2015-10-08       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.